Provenge Immunotherapy for Prostate Cancer

Image credit: drugs.com

What is Provenge?

Provenge is the first therapeutic cancer vaccine to receive approval from the U.S. Food and Drug Administration. FDA approval means it can now be part of the standard treatment for certain prostate cancer patients, rather than being used only in clinical research studies.

How is Provenge used to treat advanced prostate cancer?

Provenge is an immunotherapy medicine used to treat advanced prostate cancer in men. Provenge is mixed with certain immune cells drawn from your own blood, and the mixture is later injected into your body. This type of treatment is called autologous immunotherapy.

Is Provenge FDA approved?

Provenge is the first therapeutic cancer vaccine to receive approval from the U.S. Food and Drug Administration. FDA approval means it can now be part of the standard treatment for certain prostate cancer patients, rather than being used only in clinical research studies. How does Provenge work?

What is Provenge (Sipuleucel-T)?

(December 2015) Sipuleucel-T, sold under the brand name Provenge, developed by Dendreon Pharmaceuticals, LLC, is a cell-based cancer immunotherapy for prostate cancer (CaP). It is an autologous cellular immunotherapy.

What Is Provenge

1. https://provenge.com/
2. https://www.medicalnewstoday.com/articles/provenge
3. https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/questions-and-answers-provenge
4. https://en.wikipedia.org/wiki/Sipuleucel-T
5. https://www.drugs.com/provenge.html
6. https://www.dana-farber.org/health-library/provenge-frequently-asked-questions
7. https://news.cancerconnect.com/treatment-care/frequently-asked-questions-about-provenge-sipuleucel-t

Provenge Information

1. https://www.ema.europa.eu/en/documents/product-information/provenge-epar-product-information_en.pdf
2. https://www.dendreonmedicalaffairs.com/provenge-resources